In vitro approaches to develop weight of evidence (WoE) and mode of action (MoA) discussions with positive in vitro genotoxicity results

Mutagenesis

Volumn 22, Issue 3, 2007, Pages 161-175

  Kirkland, D J ^a   Aardema, M ^b   Banduhn, N ^c   Carmichael, P ^d   Fautz, R ^e   Meunier, J R ^f   Pfuhler, S ^b  

^a UK   (United Kingdom)

^b PROCTER AND GAMBLE COMPANY   (United States)

^c HENKEL KGAA   (Germany)

^d UNILEVER RESEARCH   (United Kingdom)

^e KAO GERMANY GMBH   (Germany)

^f L ORÉAL RECHERCHE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANEUGEN;

BACTERIAL MUTATION; CARCINOGENICITY; CONSENSUS DEVELOPMENT; CYTOTOXICITY; DNA DAMAGE; DNA REPAIR; DNA SYNTHESIS INHIBITION; ENZYME INHIBITION; ENZYME RELEASE; FEEDING; GENE MUTATION; GENOTOXICITY; HEALTH HAZARD; HUMAN; HUMAN EXPERIMENT; IN VITRO STUDY; IN VIVO STUDY; LIPID PEROXIDATION; MAMMAL CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DENATURATION; REVIEW; RISK ASSESSMENT;

ANIMALIA; RODENTIA;

EID: 34548427752     PISSN: 02678357     EISSN: 14643804     Source Type: Journal    
DOI: 10.1093/mutage/gem006     Document Type: Review

References (170)

1. Kirkland, D., Aardema, M., Henderson, L. and Müller, L. (2005) Evaluation of the ability of a battery of 3 in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens. I. Sensitivity, specificity and relative predictivity. Mutat. Res., 584, 1-256.
2. ICH (1995) Topic S2A, Genotoxicity: Guidance on Specific Aspects of Regulatory Genotoxicity Tests for Pharmaceuticals, International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. Harmonised Tripartite Guideline CPMP/ICH/141/95, approved September 1995. London: European Medicines Evaluation Agency.
3. ICH (1997) Topic S2B, Genotoxicity: A Standard Battery for Genotoxicity Testing of Pharmaceuticals, International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. Step 4 Guideline, 16 July 1997. London: European Medicines Evaluation Agency.
4. TGD (2003) Technical Guidance Document. 2nd edn. European Chemicals Bureau, Joint Research Centre, Italy (http://ecb.jrc.it/new-chemicals/ documents - accessed December 2003).
5. BfR (2002) Strategies for Genotoxicity Testing of Substances, an Overview. (http://www.bfr.bund.de/cms/media.php/94).
6. COM (2000) Guidance on a Strategy for Testing of Chemicals for Mutagenicity, Committee on Mutagenicity of Chemicals in Food, Consumer Products and the Environment. ((http://www.doh.gov.uk/com/guidance.pdf - accessed December 2000).
7. FDA (2000) Office of Food Additive Safety, Toxicological Principles for the Safety Assessment of Food Ingredients, Redbook 2000. US Food and Drug Administration, (http://vm.cfsan.fda.gov/~redbook/red-toca.html).
8. SCCP (2006) Updated Recommended Strategy for Testing Oxidative Hair Dye Substances for their Potential Mutagenicity/Genotoxicity. SCCP/0971/06, 28th March 2006.
9. SCCNFP (2004) Recommended Mutagenicity/Genotoxicity Tests for the Safety Testing of Cosmetic Ingredients to be Included in the Annexes to Council Directive 76/768/EEC. SCCNFP/0755/03, Adopted 23 April 2004.
10. FDA (2004) Guidance for Industry Recommended Approaches to Integration of Genetic Toxicology Study Results. Draft Guidance. Genotoxicity. Center for Drug Evaluation and Research,
11. Snyder, R. D. and Green, J. W. (2001) A review of the genotoxicity of marketed pharmaceuticals. Mutat. Res., 488, 151-169.
12. Matthews, E. J., Kruhlak, N. L., Cimino, M. C., Benz, R. D. and Contrera, J. F. (2006) An analysis of genetic toxicity, reproductive and developmental toxicity, and carcinogenicity data: I. Identification of carcinogens using surrogate endpoints. Regul. Toxicol. Pharmacol., 44, 83-96.
13. Scott, D., Galloway, S. M., Marshall, R. R., Ishidate, M., Jr, Brusick, D., Ashby, J. and Myhr, B. C. (1991) Genotoxicity under extreme culture conditions. A Report from ICPEMC Task Group 9. Mutat. Res., 257, 147-204.
14. Kirsch-Volders, M., Aardema, M. and Elhajouji, A. (2000) Concepts of threshold in mutagenesis and carcinogenesis. Mutat. Res., 464, 3-11.
15. Müller, L. and Kasper, P. (2000) Human biological relevance and the use of threshold-arguments in regulatory genotoxicity assessment: experience with pharmaceuticals. Mutat. Res., 464, 19-34.
16. Bentley, K. S., Kirkland, D., Murphy, M. and Marshall, R. (2000) Evaluation of thresholds for benomyl- and carbendazim-induced aneuploidy in cultured human lymphocytes using fluorescence in situ hybridization. Mutat. Res., 464, 41-51.
17. Parry, J. M., Fielder, R. J. and McDonald, A. (1994) Thresholds for aneuploidy-inducing chemicals. Mutagenesis, 9, 503-504.
18. Parry, J. M., Jenkins, G. J. S., Haddad, F., Bourner, R. and Parry, E. M. (2000) In vitro and in vivo extrapolations of genotoxin exposures: consideration of factors which influence dose-response thresholds. Mutat. Res., 464, 53-63.
19. Sofuni, T., Hayashi, M., Nohmi, T., Matsuoka, A., Yamada, M. and Kamata, E. (2000) Semi-quantitative evaluation of genotoxic activity of chemical substances and evidence for a biological threshold of genotoxic activity. Mutat. Res., 464, 97-104.
20. Madle, S., von der Hude, W., Broschinski, L. and Jänig, G.-R. (2000) Threshold effects in genetic toxicity: perspective of chemicals regulation in Germany. Mutat. Res., 464, 117-121.
21. Henderson, L., Albertini, S. and Aardema, M. (2000) Thresholds in genotoxicity responses. Mutat. Res., 464, 123-128.
22. Crebelli, R. (2000) Threshold-mediated mechanisms in mutagenesis: implications in the classification and regulation of chemical mutagens. Mutat. Res., 464, 129-135.
23. Kirkland, D. J. and Müller, L. (2000) Interpretation of the biological relevance of genotoxicity test results: the importance of thresholds. Mutat. Res., 464, 137-147.
24. Snyder, R. D., Ewing, D. and Hendry, L. B. (2006) DNA intercalative potential of marketed drugs testing positive in in vitro cytogenetics assays. Mutat. Res., 609, 47-59.
25. Phillips, D. H., Farmer, P. B., Beland, F. A., Nath, R. G., Poirier, M. C., Reddy, M. V. and Turteltaub, K. W. (2000) Methods of DNA adduct determination and their application to testing compounds for genotoxicity. Environ. Mol. Mutagen., 35, 222-233.
26. Guengerich, F. P., Dannan, G. A., Wright, S. T., Martin, M. V. and Kaminsky, L. S. (1982) Purification and characterization of liver microsomal cytochromes P-450: electrophoretic, spectral, catalytic and immunochemical properties and inducibility of eight isozymes isolated from rats treated with phenobarbital or beta-naphthoflavone. Biochemistry, 21, 6019-6030.
27. Beaune, P., Lemestre-Cornet, R., Kremers, P., Albert, A. and Giele, J. (1985) The Salmonella/mammalian microsome mutagenicity test: comparison of human and rat livers as activating systems. Mutat. Res., 156, 139-146.
28. Hakura, A., Suzuki, S. and Satoh, T. (1999) Advantage of the use of human liver S9 in the Ames test. Mutat. Res., 438, 29-36.
29. Doehmer, J., Seidel, A., Oesch, F. and Glatt, H. R. (1990) Genetically engineered V79 Chinese hamster cells metabolically activate the cytostatic drugs cyclophosphamide and ifosfamide. Environ. Health Perspect., 88, 63-65.
30. Ellard, S., Mohammad, Y., Dogra, S., Wölfel, C., Doehmer, J. and Parry, J. M. (1991) The sue of genetically engineered V79 Chinese hamster cultures expressing rat liver CYP1A1, 1A2 and 2B1 cDNAs in micronucleus assays. Mutagenesis, 6, 461-470.
31. Nakagawa, T., Sawada, M., Gonzalez, F. J., Yokoi, T. and Kamataki, T. (1996) Stable expression of human CYP2E1 in Chinese hamster cells: high sensitivity to N,N-dimethylnitrosamine in cytotoxicity testing. Mutat. Res., 360, 181-186.
32. Crespi, C. L., Gonzalez, F. J., Steimel, D. T., Turner, T. R., Gelboin, H. V., Penman, B. W. and Langenbach, R. (1991) A metabolically competent human cell line expressing five cDNAs encoding procarcinogen-activating enzymes: application to mutagenicity testing. Chem. Res. Toxicol., 4, 566-572.
33. Crofton-Sleigh, C., Doherty, A., Ellard, S., Parry, E. M. and Venitt, S. (1993) Micronucleus assays using cytochalasin-blocked MCL-5 cells, a proprietary human cell line expressing five human cytochromes P-450 and microsomal epoxide hydrolase. Mutagenesis, 8, 363-372.
34. Mace, K., Aguilar, F., Wang, J.-S., Vautravers, P., Gomez-Loechon, M., Gonzalez, F. J., Groopman, J., Harris, C. C. and Pfeifer, A. M. A. (1997) Aflatoxin B1-induced DNA adduct formation and p53 mutations in CYP450-expressing human liver cell lines. Carcinogenesis, 18, 1291-1297.
35. Ku, W. W., Bigger, A., Brambilla, G. et al. (2006) Strategy for genotoxicity testing and stratification of genotoxicity test results - metabolic considerations. Mutat. Res., 627, 59-77.
36. Yoshikawa, K., Isobe, M., Watabe, T. and Takabatake, E. (1980) Studies on metabolism and toxicity of styrene. III. The effect of metabolic activation by rat-liver S9 on the mutagenicity of phenyloxirane toward Salmonella typhimurium. Mutat. Res., 78, 219-226.
37. Glatt, H. R., Utesch, D. and Oesch, F. (1985) Hepatocyte- but not S9-mediated mutagenicity correlates with the carcinogenicity of methylbenz(a)anthracenes. In Cooke, M. and Dennis, A. J. (eds), Polycyclic Aromatic Hydrocarbons: Mechanisms, Methods and Metabolism. Proceedings of the Eighth International Symposium. Battelle Press, Columbus, OH, pp. 475-484.
38. Recio, L. and Hsie, A. W. (1988) Detoxication mechanisms of benzo(a)pyrene as studied in the CHO assay. In Cooke, M. and Dennis, A. J. (eds), Polynuclear Aromatic Hydrocarbons: A Decade of Progress. Proceedings of the Tenth International Symposium. Battelle Press, Columbus, OH, pp. 761-772.
39. Hu, T., Miller, C. M., Ridder, G. M. and Aardema, M. J. (1999) Characterization of p53 in Chinese hamster cell lines CHO-K1, CHO-WBL and CHL: implications for genotoxicity testing. Mutat. Res., 426, 51-62.
40. +/- cell line is heterozygous for a codon 170 mutation in the p53 tumor suppressor gene. Mutat. Res., 373, 157-165.
41. Chaung, W., Mi, L.-J. and Boorstein, R. J. (1997) The p53 status of Chinese hamster V79 cells frequently used for studies on DNA damage and DNA repair. Nucleic Acids Res., 25, 992-994.
42. Hilliard, C. A., Armstrong, M. J., Bradt, C. I., Hill, R. B., Greenwood, S. K. and Galloway, S. M. (1998) Chromosome aberrations in vitro related to cytotoxicity of nonmutagenic chemicals and metabolic poisons. Environ. Mol. Mutagen., 31, 316-326.
43. Hilliard, C., Hill, R., Armstrong, M., Fleckenstein, C., Crowley, J., Freeland, E., Duffy, D. and Galloway, S. M. (2007) Chromosome aberrations in Chinese hamster and human cells: a comparison using compounds with various genotoxicity profiles. Mutat. Res., 616, 103-118.
44. Voelkerding, K. V., Steffen, D. W., Zaidi, S. H. and Malter, J. S. (1995) Post-transcriptional regulation of the p53 tumor suppressor gene during growth-induction of human peripheral blood mononuclear cells. Oncogene, 10, 515-521.
45. Katsumoto, T., Higaki, K., Ohno, K. and Onodera, K. (1995) Cell-cycle dependent biosynthesis and localization of p53 protein in untransformed human cells. Biol. Cell, 84, 167-173.
46. Tweats, D. J. and Gatehouse, D. G. (1988) Further debate of testing strategies. Mutagenesis, 3, 95-102.
47. Halliwell, B. (2003) Oxidative stress in cell culture: an under-appreciated problem? FEBS Letters, 540, 3-6.
48. Wee, L. M., Long, L. H., Whiteman, M. and Halliwell, B. (2003) Factors affecting the ascorbate- and phenolic-dependent generation of hydrogen peroxide in Dulbecco's modified Eagles medium. Free Radic. Res., 37, 1123-1130.
49. Tennant, R. W., Margolin, B. H., Shelby, M. D. et al. (1987) Prediction of chemical carcinogenicity in rodents from in vitro genetic toxicity assays. Science, 236, 933-941.
50. Zeiger, E., Haseman, J. K., Shelby, M. D., Margolin, B. H. and Tennant, R. W. (1990) Evaluation of four in vitro genetic toxicity tests for predicting rodent carcinogenicity: confirmation of earlier results with 41 additional chemicals. Environ. Mol. Mutagen., 16 (Suppl. 18), 1-14.
51. Gatehouse, D. (1987) Critical features of bacterial mutation assays. Mutagenesis, 2, 397-409.
52. Aeschbacher, H.-U., Finot, P. A. and Wolleb, U. (1983) Interactions of histidine containing substances and extraction methods with the Ames mutagenicity test. Mutat. Res., 113, 103-116.
53. Arenaz, P., Hallberg, L., Mancillas, F., Gutierrez, G. and Garcia, S. (1989) Sodium azide mutagenesis in mammals: inability of mammalian cells to convert azide to a mutagenic intermediate. Mutat. Res., 227, 63-67.
54. Slamenova, D. and Gabelova, A. (1980) The effects of sodium azide on mammalian cells cultivated in vitro. Mutat. Res., 71, 263-267.
55. Martin, C. N., McDermid, A. C. and Garner, R. C. (1978) Testing of known carcinogens and noncarcinogens for their ability to induce unscheduled DNA synthesis in HeLa cells. Cancer Res., 38, 2621-2627.
56. NTP (1991) Toxicology and carcinogenesis studies on sodium azide (CAS: 26628-22-8) in F344 rats (gavage studies). Natl. Toxicol. Program Tech. Rep. Ser., 389, 1-165.
57. Bauer, S. L. and Howard, P. C. (1991) Kinetics and cofactor requirements for the nitroreductive metabolism of 1-nitropyrene and 3-nitrofluoranthene by rabbit liver aldehyde oxidase. Carcinogenesis, 12, 1545-1549.
58. Suter, W., Hartmann, A., Pötter, F., Sagelsdorff, P., Hoffmann, P. and Martus, H.-J. (2002) Genotoxicity assessment of the antiepileptic drug AMP397, an Ames-positive aromatic nitro compound. Mutat. Res., 518, 181-194.
59. Thornton-Manning, J. R., Smith, B. A., Beland, F. A. and Heflich, R. H. (1991) S9-mediated metabolism of 1-nitropyrene to a mutagen in Chinese hamster ovary cells by ring-oxidation under aerobic conditions and by nitroreduction under anaerobic conditions. Carcinogenesis, 12, 2317-2323.
60. Levine, W. G., Stoddart, A. and Zbaida, S. (1992) Multiple mechanisms in hepatic microsomal azoreduction. Xenobiotica, 22, 1111-1120.
61. Collier, S. W., Storm, J. E. and Bronaugh, R. L. (1993) Reduction of azo dyes during in vitro percutaneous absorption. Toxicol. Appl. Pharmacol., 118, 73-79.
62. CHMP (2006) Committee for Medicinal Products for Human Use, Guideline on the Limits of Genotoxic Impurities. EMEA/CHMP/SWP/5199/02 and EMEA/CHMP/QWP/251344/2006, adopted June 2006.
63. Cozzarelli, N. R. (1977) The mechanism of action of inhibitors of DNA synthesis. Ann. Rev. Biochem., 46, 641-668.
64. Galloway, S. M., Miller, J. E., Armstrong, M. J., Bean, C. L., Skopek, T. R. and Nichols, W. W. (1998) DNA synthesis inhibition as an indirect mechanism of chromosome aberrations: comparison of DNA-reactive and non-DNA-reactive clastogens. Mutat. Res., 400, 169-186.
65. Kihlman, B. A., Nichols, W. W. and Levan, A. (1963) The effect of deoxyadenosine and cytosine arabinoside on the chromosomes of human leukocytes in vitro. Hereditas, 50, 139-143.
66. Au, W. W., Johnston, D. A., Colie-Bruyere, C. and Hsu, T. C. (1980) Short-term cytogenetic assays of nine cancer chemotherapeutic drugs with metabolic activation. Environ. Mutagen., 2, 455-464.
67. Sofuni, T., Honma, M., Hayashi, M., Shimada, H., Tanaka, N., Wakuri, S., Awogi, T., Yamamoto, K. I., Nishi, Y. and Nakadate, M. (1996) Detection of in vitro clastogens and spindle poisons by the mouse lymphoma assay using the microwell method: interim report of an international collaborative study. Mutagenesis, 11, 349-355.
68. Hayashi, M., Sofuni, T., Kodama, Y., Ishidate, M., Jr and Tamura, H. (1989) Micronucleus test with 1-β-D-arabinofuranosylcytosine administered by intraperitoneal injection and oral gavage. Mutat. Res., 223, 345-348.
69. Miller, B., Pötter-Locher, F., Seelbach, A., Stopper, H., Utesch, D. and Madle, S. (1998) Evaluation of the in vitro micronucleus test as an alternative to the in vitro chromosomal aberration assay: position of the GUM working group on the in vitro micronucleus test. Mutat. Res., 410, 81-116.
70. Mersch-Sundermann, V., Schneider, U., Klopman, G. and Rosenkranz, H. S. (1994) SOS induction in Escherichia coli and Salmonella mutagenicity: a comparison of 330 compounds. Mutagenesis, 9, 205-224.
71. Zhang, M., Cao, Y., Ye, Y. and Zheng, J. (1988) Detection of the mutagenicity of phosphonoacetic acid with Ames, MN and SCE tests. Nanjing Da Xue Xue Bao Zi Ran Ke Xue, 24, 114-121.
72. Becker, B. A., Bopp, B. A., Brusick, D. J. and Lehrer, S. B. (1976) Non-mutagenicity of phosphonoacetic acid (disodium salt) in in vitro tests and in rodents. Fed. Proc. Fed Am. Soc. Exp. Biol., 35, 533.
73. Moore, R. C. and Randall, C. (1987) Different effects of 1-beta-D-arabinofuranosylcytosine and aphidicolin in S-phase cells - chromosome aberrations, cell-cycle delay and cytotoxicity. Mutat. Res., 178, 73-80.
74. Tedeschi, B., Cicchetti, R., Argentin, G., Caporossi, D., Pittaluga, M., Parisi, P. and Vernole, P. (2004) Aphidicolin and bleomycin induced chromosome damage as biomarker of mutagen sensitivity: a twin study. Mutat. Res., 546, 55-64.
75. Aardema, M. J., Gibson, D. P. and LeBoeuf, R. A. (1989) Sodium fluoride-induced chromosome aberrations in different stages of the cell cycle: a proposed mechanism. Mutat. Res., 223, 191-203.
76. Ikegami, S., Taguchi, T., Ohashi, M., Oguro, M., Nagano, H. and Mano, Y. (1978) Aphidicolin prevents mitotic cell division by interfering with the activity of DNA polymerase. Nature, 275, 458-460.
77. Yoshida, S., Yamada, M. and Masaki, S. (1977) Inhibition of DNA polymerase α and β of calf thymus by 1-β-D- arabinofuranosylcytosine-5′-phosphate. Biochim. Biophys. Acta, 477, 144-150.
78. Sina, J. F., Bean, C. L., Dysart, G. R., Taylor, V. I. and Bradley, M. O. (1983) Evaluation of the alkaline elution/rat hepatocyte assay as a predictor of carcinogenic/mutagenic potential. Mutat. Res., 113, 357-391.
79. Andrews, B. J. and Turchi, J. J. (2004) Development of a high-throughput screen for inhibitors of replication protein A and its role in nucleotide excision repair. Mol. Cancer Ther., 3, 385-391.
80. DeMarini, D. M. and Lawrence, B. K. (1992) Prophage induction by DNA polymerase II poisons and reactive-oxygen species: role of DNA breaks. Mutat. Res., 267, 1-17.
81. van der Lelie, D., Regniers, L., Borremans, B., Provost, A. and Verschaeve, L. (1997) The VITOTOX test, an SOS bioluminescence test to measure genotoxicity kinetics. Mutat. Res., 389, 279-290.
82. Ignatius, A., Hund, M. and Tempel, K. (1992) Poly(ADP-ribose)polymerase- activity of chicken embryo cells exposed to nucleotoxic agents. Toxicology, 76, 187-196.
83. Albertini, S., Chételat, A.-A., Miller, B., Muster, W., Pujadas, E., Strobel, R. and Gocke, E. (1995) Genotoxicity of 17 gyrase- and four mammalian topoisomerase II-poisons in prokaryotic and eukaryotic test systems. Mutagenesis, 10, 343-351.
84. Snyder, R. D. and Gilles, P. J. (2002) Evaluation of the clastogenic, DNA intercalative, and topoisomerase II-interactive properties of bioflavonoids in Chinese hamster V79 cells. Environ. Mol. Mutagen., 40, 266-276.
85. Ferguson, L. R. and Baguley, B. C. (1996) Mutagenicity of anticancer drugs that inhibit topoisomerase enzymes. Mutat. Res., 355, 91-101.
86. Ferguson, L. R. (1998) Inhibitors of topoisomerase II enzymes: a unique group of environmental mutagens and carcinogens. Mutat. Res., 400, 271-278.
87. Lynch, A., Harvey, J., Aylott, M., Nicholas, E., Burman, M., Siddiqui, A., Walker, S. and Rees, R. (2003) Investigations into the concept of a threshold for topoisomerase inhibitor-produced clastogenicity. Mutagenesis, 18, 345-353.
88. Snyder, R. D. and Strekowski, L. (1999) Enhancement of bleomycin-induced micronucleus formation in V79 cells as a rapid and sensitive screen for non-covalent DNA-binding compounds. Mutat. Res., 444, 181-192.
89. Loizou, J. I., El-Khamisy, S. F., Zlatanou, A., Moore, D. J., Chan, D. W., Qin, J., Sarno, S., Meggio, F., Pinna, L. A. and Caldecott, K. W. (2004) The protein kinase CK2 facilitates repair of chromosomal DNA singlestrand breaks. Cell, 117, 17-28.
90. Bailey, S. M., Brenneman, M. A., Halbrook, J., Nickoloff, J. A., Ullrich, R. L. and Goodwin, E. H. (2004) The kinase activity of DNA-PK is required to protect mammalian telomeres. DNA Repair, 4, 225-233.
91. Bassi, L., Buzzi, R., Fiore, M. and Palitti, F. (2000) Clastogenic effects of two tyrosine kinase inhibitors, Tyrphostin 23 and Tyrphostin 46, on a transformed (CHO-K1) and on a primary embryonic Chinese hamster cell line (CHE). Mutagenesis, 15, 341-347.
92. Kunz, B. A. (1982) Genetic effects of deoxyribonucleotide pool imbalances. Environ. Mol. Mutagen., 4, 695-725.
93. Kunz, B. A. (1988) Mutagenesis and deoxyribonucleotide pool imbalance. Mutat. Res., 200, 133-147.
94. Kunz, B. A., Kohalmi, S. E., Kunkel, T. A., Mathews, C. K., McIntosh, E. M. and Reidy, J. A. (1994) International Commission for Protection against Environmental Mutagens and Carcinogens. Deoxyribonucleotide triphosphate levels: a critical factor in maintenance of genetic stability. Mutat. Res., 318, 1-64.
95. Kawai, K., Nozawa, Y., Mori, H. and Ogihara, Y. (1986) Inhibition of mitochondrial respiration by flavoskyrin, a toxic metabolite of Penicillium islandicum Spp. Toxicol. Lett., 30, 105-111.
96. Kawai, K., Shiojiri, H., Nakamura, T., Nozawa, Y., Sugie, S., Mori, H., Kato, T. and Ogihara, Y. (1985) Cytotoxicity and genotoxicity of xenoclauxin and desacetylduclauxin from Penicillium duclauxii (Delacroix). Cell Biol. Toxicol., 1, 1-10.
97. Kawai, K., Mori, H. and Kitamura, J. (1983) The uncoupling effect of flavoglaucin, a quinol pigment from Aspergillus chevalieri (Mangin) on mitochondrial respiration. Toxicol. Lett., 19, 321-325.
98. Jansson, K. and Jansson, V. (1986) Inability of chlorophenols to induce 6-thioguanine-resistant mutants in V79 Chinese hamster cells. Mutat. Res., 171, 165-168.
99. Kawai, K., Mori, H., Sugie, S., Yoshimi, N., Inoue, T., Nakamura, T., Nozawa, Y. and Matsushima, T. (1986) Genotoxicity in the hepatocyte/DNA repair test and toxicity to liver mitochondria of 1-hydroxyanthraquinone and several dihydroxyanthraquinones. Cell Biol. Toxicol., 2, 457-467.
100. Mitchell, J. S. and Simon-Reuss, I. (1952) Experiments on the mechanism of action of tetrasodium 2-methyl-1:4-naphthohydroquinone diphosphate as a mitotic inhibitor and radiosensitiser, using the technique of tissue culture: relation between cytological effects and chemical constitution. Br. J. Cancer, 6, 317-338.
101. Rahn, C. A., Bombick, D. W. and Doolittle, D. J. (1991) Assessment of mitochondrial membrane potential as an indicator of cytotoxicity. Fundam. Appl. Toxicol., 16, 435-448.
102. Huang, Q.-G., Kong, L.-R., Liu, Y.-B. and Wang, L.-S. (1996) Relationships between molecular structure and chromosomal aberrations in in vitro human lymphocytes induced by substituted nitrobenzenes. Bull. Environ. Contam. Toxicol., 57, 349-353.
103. Wild, D., Eckhardt, K., Harnasch, D. and King, M.-T. (1983) Genotoxicity study of CS (ortho-chlorobenzylidenemalononitrile) in Salmonella, Drosophila, and mice. Failure to detect mutagenic effects. Arch. Toxicol., 54, 167-170.
104. Bhattacharya, R. and Rao, P. V. L. (1997) Cyanide induced DNA fragmentation in mammalian cell cultures. Toxicology, 123, 207-215.
105. Vock, E. H., Lutz, W. K., Hormes, P., Hoffmann, H. D. and Vamvakas, S. (1998) Discrimination between genotoxicity and cytotoxicity in the induction of DNA double-strand breaks in cells treated with etoposide, melphalan, cisplatin, potassium cyanide, Triton X-100, and γ-irradiation. Mutat. Res., 413, 83-94.
106. Bergman, K., Müller, L. and Weberg Teigen, S. (1996) The genotoxicity and carcinogenicity of paracetamol: a regulatory (re)view. Mutat. Res., 349, 263-288.
107. Valko, M., Izakovic, M., Mazur, M., Rhodes, C. J. and Telser, J. (2004) Role of oxygen radicals in DNA damage and cancer incidence. Mol. Cell. Biochem., 266, 37-56.
108. Loft, S., Deng, X. S., Tuo, J., Wellejus, A., Sárensen, M. and Poulsen, H. E. (1998) Experimental study of oxidative DNA damage. Free Radic. Res., 29, 525-539.
109. Beddowes, E. J., Faux, S. P. and Chipman, J. K. (2003) Chloroform, carbon tetrachloride and glutathione depletion induce secondary genotoxicity in liver cells via oxidative stress. Toxicology, 187, 101-115.
110. Cicchetti, R. and Argentin, G. (2003) The role of oxidative stress in the in vitro induction of micronuclei by pesticides in mouse lung fibroblasts. Mutagenesis, 18, 127-132.
111. Djelic, N. and Anderson, D. (2003) The effect of the antioxidant catalase on oestrogens, triiodothyronine, and noradrenaline in the comet assay. Teratog. Carcinog. Mutagen., (Suppl. 2), 69-81.
112. do Ceu Silva, M., Gaspar, J., Silva, I. D., Leao, D. and Rueff, J. (2003) Induction of chromosomal aberrations by phenolic compounds: possible role of reactive oxygen species. Mutat. Res., 540, 29-42.
113. Lee, K. W., Lee, H. J. and Lee, C. Y. (2004) Vitamins, phytochemicals, diets, and their implementation in cancer chemoprevention. Crit. Rev. Food Sci. Nutr., 44, 437-452.
114. Kruman, I. I., Kumaravel, T. S., Lohani, A., Pedersen, W. A., Cutler, R. G., Kruman, Y., Haughey, N., Lee, J., Evans, M. and Mattson, M. P. (2002) Folic acid deficiency and homocysteine impair DNA repair in hippocampal neurons and sensitize them to amyloid toxicity in experimental models of Alzheimer's disease. J. Neurosci., 22, 1752-1762.
115. Pitozzi, V., Giovannelli, L., Bardini, G., Rotella, C. M. and Dolara, P. (2003) Oxidative DNA damage in peripheral blood cells in type 2 diabetes mellitus: higher vulnerability of polymorphonuclear leukocytes. Mutat. Res., 529, 129-1-33.
116. Gielazyn, M. L., Ringwood, A. H., Piegorsch, W. W. and Stancyk, S. E. (2003) Detection of oxidative DNA damage in isolated marine bivalve hemocytes using the comet assay and formamidopyrimidine glycosylase (Fpg). Mutat. Res., 542, 15-22.
117. Horvathova, E., Slamenova, D. and Gabelova, A. (1999) Use of single cell electrophoresis (comet assay) modifications for analysis of DNA damage. Gen. Physiol. Biophys., 18, 70-74.
118. Turver, C. J., Poole, A. and Brown, R. C. (1985) Lipid peroxidation and the generation of malonaldehyde in crocidolite-treated cell cultures. In Beck, E. G. and Bignon, J. (eds), In vitro Effects of Mineral Dusts; Third International Workshop, Schluchsee, West Germany, October 1-4, 1984. NATO Advanced Science Institute Series G, Ecological Science, volume 3. Springer-Verlag, New York, pp. 267-274.
119. Sunderman, F. W. (1989) Mechanisms of nickel carcinogenesis. Scand. J. Work Environ. Health, 15, 1-12.
120. Silberhorn, E. M., Glauert, H. P. and Robertson, L. W. (1990) Carcinogenicity of polyhalogenated biphenyls: PCBs and PBBs. CRC Crit. Rev. Toxicol., 20, 440-496.
121. Sugiyama, M. (1994) Role of cellular antioxidants in metal-induced damage. Cell Biol. Toxicol., 10, 1-22.
122. Hsu, C.-H., Quistad, G. B. and Casida, J. E. (1998) Phosphine-induced oxidative stress in hepa 1c1c7 cells. Toxicol. Sci., 46, 204-210.
123. Lim, P., Wuenschell, G. E., Holland, V., Lee, D. H., Pfeifer, G. P., Rodriguez, H. and Termini, J. (2004) Peroxyl radical mediated oxidative DNA damage: implications for lipid peroxidation induced mutagenesis. Biochemistry, 14, 15339-15348.
124. Muldoon, D. F., Hassoun, E. A. and Stohs, S. J. (1992) Ricin-induced hepatic lipid peroxidation, glutathione depletion, and DNA single-strand breaks in mice. Toxicon, 30, 977-984.
125. Lam, C.-W., Casanova, M. and Heck, H. d'A. (1985) Depletion of nasal mucosal glutathione by acrolein and enhancement of formaldehydeinduced DNA-protein cross-linking by simultaneous exposure to acrolein. Arch. Toxicol., 58, 67-71.
126. Merrick, B. A., Smallwood, C. L., Meier, J. R., McKean, D. L., Kaylor, W. H. and Condie, L. W. (1987) Chemical reactivity, cytotoxicity, and mutagenicity of chloropropanones. Toxicol. Appl. Pharmacol., 91, 46-54.
127. McCarthy, T. J., Hayes, E. P., Schwartz, C. S. and Witz, G. (1994) The reactivity of selected acrylate esters toward glutathione and deoxyribonucleotides in vitro: structure-activity relationships. Fundam. Appl. Toxicol., 22, 543-548.
128. Bolt, H. M. (1993) Interspecies differences in metabolism and kinetics of 1,3-butadiene, isobutene and styrene. In Sorsa, M., Peltonen, K., Vainio, H. and Hemminki, K. (eds), Butadiene and Styrene: Assessment of Health Hazards. IARC, Lyon, France, pp. 37-44IARC Scientific Publications No. 127.
129. Stohs, S. J. and Bagchi, D. (1995) Oxidative mechanisms in the toxicity of metal ions. Free Rad. Biol. Med., 18, 321-326.
130. Yamano, T. (1996) Dissociation of DDVP-induced DNA strand breaks from oxidative damage in isolated rat hepatocytes. Toxicology, 108, 49-56.
131. Wangenheim, J. and Bolcsfoldi, G. (1988) Mouse lymphoma L5178Y thymidine kinase locus assay of 50 compounds. Mutagenesis, 3, 193-205.
132. Bradley, M. O., Taylor, M. I., Armstrong, M. J. and Galloway, S. M. (1987) Relationships among cytotoxicity, lysosomal breakdown, chromosome aberrations, and DNA double-strand breaks. Mutat. Res., 189, 69-79.
133. Duncan, C. J., Greenaway, H. C. and Smith, J. L. (1980) 2,4-dinitrophenol, lysosomal breakdown and rapid myofilament degradation in vertebrate skeletal muscle. Nauyn-Schmeidebergs Arch. Pharmacol., 315, 77-82.
134. Allison, A. C. (1971) Lysosomes and the toxicity of particulate pollutants. Arch. Int. Med., 128, 131-139.
135. Kohli, K. K., Siddiqui, F. A. and Venkitasubramanian, T. A. (1977) Effect of dieldrin on the stability of lysosomes in the rat liver. Bull. Environ. Contam. Toxicol., 18, 617-623.
136. Tsutsui, T., Suzuki, N. and Ohmori, M. (1984) Sodium fluoride-induced morphological and neoplastic transformation, chromosome aberrations, sister chromatid exchanges and unscheduled DNA synthesis, in cultured Syrian hamster embryo cells. Cancer Res., 44, 938-941.
137. Tsutsui, T., Suzuki, N., Ohmori, M. and Maizumi, H. (1984) Cytotoxicity, chromosome aberrations and unscheduled DNA synthesis in cultured human diploid fibroblasts induced by sodium fluoride. Mutat. Res., 139, 193-198.
138. Tsutsui, T., Ide, K. and Maizumi, H. (1984) Induction of unscheduled DNA synthesis in cultured human oral keratinocytes by sodium fluoride. Mutat. Res., 140, 43-48.
139. +/-(3.7.2)] mouse lymphoma cells. Mutagenesis, 1, 157-167.
140. Slamenova, D., Gabelova, A. and Ruppova, K. (1992) Cytotoxicity and genotoxicity testing of sodium fluoride on Chinese hamster V79 cells and human EUE cells. Mutat. Res., 279, 109-115.
141. Gurr, J.-R., Lin, Y.-C., Ho, I.-C., Jan, K.-Y. and Lee, T.-C. (1993) Induction of chromatid breaks and tetraploidy in Chinese hamster ovary cells by treatment with sodium arsenite during the G2 phase. Mutat. Res., 319, 135-142.
142. Dusinska, M. and Slamenova, D. (1990) Effect of silver compounds on in vitro cultured mammalian cells: II. Study of genotoxicity and the effect of diamminesilver tetraborate on macromolecular synthesis of V79 cells. Biologia (Bratisl), 45, 211-218.
143. Norred,W. P., Bacon, C. W., Porter, J. K. and Voss, K. A. (1990) Inhibition of protein synthesis in primary rat hepatocytes by extracts of Fusarium moniliforme contaminated corn. Food Chem. Toxicol., 28, 89-94.
144. Grosse, Y., Baudrimont, I., Castegnaro, M., Betbeder, A.-M., Creppy, E. E., Dirheimer, G. and Pfohl-Leszkowicz, A. (1995) Formation of ochratoxin A metabolites and DNA-adducts in monkey kidney cells. Chem. Biol. Interact., 95, 175-187.
145. Ashby, J., Mohammed, R. and Callander, R. D. (1987) N-chloropiperidine and calcium hypochlorite: possible examples of toxicity-dependent clastogenicity in vitro. Mutat. Res., 189, 59-68.
146. Elhajouji, A., van Hummelen, P. and Kirsch-Volders, M. (1995) Indications for a threshold of chemically-induced aneuploidy in vitro in human lymphocytes. Environ. Mol. Mutagen., 26, 292-304.
147. Elhajouji, A., Tibaldi, F. and Kirsch-Volders, M. (1997) Indication for thresholds of chromosome non-disjunction versus chromosome lagging induced by spindle inhibitors in vitro in human lymphocytes. Mutagenesis, 12, 133-140.
148. Marshall, R. R., Murphy, M., Kirkland, D. J. and Bentley, K. S. (1996) Fluorescence in situ hybridisation with chromosome-specific centromeric probes: a sensitive method to detect aneuploidy. Mutat. Res., 372, 233-245.
149. Zijno, A., Marcon, F., Leopardi, P. and Crebelli, R. (1996) Analysis of chromosome segregation in cytokinesis-blocked human lymphocytes: non-disjunction is the prevalent damage resulting from low dose exposure to spindle poisons. Mutagenesis, 11, 335-340.
150. Kirkland, D. J. (1992) Chromosomal aberration tests in vitro: problems with protocol design and interpretation of results. Mutagenesis, 7, 95-106.
151. Galloway, S. M. (2000) Cytotoxicity and chromosome aberrations in vitro: experience in industry and the case for an upper limit on toxicity in the aberration assay. Environ. Mol. Mutagen., 35, 191-201.
152. Kirkland, D. J. and Clements, J. (1998) Recommendations for spacing of test chemical concentrations in the mouse lymphoma tk mutation assay (MLA). Mutat. Res., 415, 159-163.
153. Armstrong, M. J., Bean, C. L. and Galloway, S. M. (1992) A quantitative assessment of the cytotoxicity associated with chromosomal aberration detection in Chinese hamster ovary cells. Mutat. Res., 265, 45-60.
154. Greenwood, S. K., Hill, R. B., Sun, J. T., Armstrong, M. J., Johnson, T. E., Gara, J. P. and Galloway, S. M. (2004) Population doubling: a simple and more accurate estimation of cell growth suppression in the in vitro assay for chromosomal aberrations that reduces irrelevant positive results. Environ. Mol. Mutagen., 43, 36-44.
155. Kihlman, B. A. and Natarajan, A. T. (1984) Potentiation of chromosomal alterations by inhibitors of DNA repair. In Collins, A., Downes, C. S. and Johnson, R. T. (eds), DNA Repair and Its Inhibition. IRL Press, Oxford, pp. 319-339.
156. Benedict, W. F., Banerjee, A., Gardner, A. and Jones, P. A. (1977) Induction of morphological transformation in mouse C3H/10T1/2 clone 8 cells and chromosomal damage in hamster A(T1)C1-3 cells by cancer chemotherapeutic agents. Cancer Res., 37, 2202-2208.
157. Degrassi, F., De Salvia, R., Tanzarella, C. and Palitti, F. (1989) Induction of chromosomal aberrations and SCE by camptothecin, an inhibitor of mammalian topoisomerase I. Mutat. Res., 211, 125-130.
158. Deaven, L. L., Oka, M. S. and Tobey, R. A. (1978) Cell-cycle specific chromosome damage following treatment of cultured Chinese hamster cells with 4′-((9-acridinyl)-amino)methanesulfon-m-anisidine-HCl. J. Natl. Cancer Inst., 60, 1155-1161.
159. Gaulden, M. E. (1987) Hypothesis: some mutagens directly alter specific chromosomal proteins (DNA topoisomerase II and peripheral proteins) to produce chromosome stickiness, which causes chromosome aberrations. Mutagenesis, 2, 357-365.
160. Palitti, F., Degrassi, F., De Salvia, R., Fiore, M. and Tanzarella, C. (1990) In Obe, G. and Natarajan, A. T. (eds), Chromosomal Aberrations: Basic and Applied Aspects. Springer, Heidelberg, pp. 50-60.
161. MacPhee, D. G., Haynes, R. H., Kunz, B. A. and Anderson, D. (1988) Editorial introduction. Mutat. Res., 200, 3-4.
162. Kihlman, B. A. (1957) Experimentally induced chromosome aberrations in plants. I. The production of chromosome aberrations by cyanide and other heavy metal complexing agents. J. Biophys. Biochem. Cytol., 3, 363-380.
163. Umeda, M. and Nishimura, M. (1979) Inducibility of chromosomal aberrations by metal compounds in cultured mammalian cells. Mutat. Res., 67, 221-229.
164. Nicotera, T. M., Block, A. W., Gibas, Z. and Sandberg, A. A. (1985) Induction of superoxide dismutase, chromosomal aberrations and sister-chromatid exchanges by paraquat in Chinese hamster fibroblasts. Mutat. Res., 151, 263-268.
165. Tsuda, H. (1981) Enhancing effect of tumor promoter, 12-O- tetradecanoylphorbol-13-acetate on 8-azaguanine-resistant mutations induced by N-methyl-N′-nitro-N-nitrosoguanidine in cultured Chinese hamster cells. Jpn. J. Genet., 56, 1-8.
166. Cerrutti, P. A., Amstrad, P. and Emerit, I. (1983) Tumor promoter phorbol-myristate-acetate induces membrane-mediated chromosomal damage. In Nygaard, O. F. and Simic, M. G. (eds), Radioreceptors and Anticarcinogens. Academic Press, New York, pp. 527-538.
167. Friedman, J., Shabtai, F., Levy, L. S. and Djaldetti, M. (1987) Chromium chloride induces chromosomal aberrations in human lymphocytes via indirect action. Mutat. Res., 191, 207-210.
168. Nowack, C. (1987) Studies on the ability of hypotonic solutions to induce chromosomal aberrations in V79 cells. Teratog. Carcinog. Mutagen., 7, 515-525.
169. Ishidate, M., Jr, Sofuni, T., Yoshikawa, K., Hayashi, M., Nohmi, T., Sawada, M. and Matsuoka, A. (1984) Primary mutagenicity screening of food additives currently used in Japan. Food Chem. Toxicol., 22, 623-626.
170. Ashby, J. (1985) The genotoxicity of sodium saccharin and sodium chloride in relation to their cancer-promoting properties. Food Chem. Toxicol., 23, 507-519.